| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $308K | -7.2% |
| Operating Income | -$958K | +6.5% |
| Interest Expense | $84K | +114.9% |
| Income Tax | $0 | — |
| Net Income | $9.4M | +957.1% |
| EPS (Diluted) | $4.37 | +956.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33K | +1060.8% |
| Current Assets | $71K | +873.9% |
| Total Assets | $171K | +59.2% |
| Current Liabilities | $1.2M | -92.6% |
| Total Liabilities | $1.2M | -92.6% |
| Stockholders' Equity | -$1.1M | +93.5% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$368K | -15.0% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $398K | +24.1% |
Business Overview
Eco Science Solutions, Inc. (ESSI) is focused on developing and commercializing enterprise software and financial technology solutions for regulated, compliance-intensive industries, with primary platforms being HERBO (a cloud-based ERP and accounting platform) and HERBO Pay (an integrated financial services and payment platform). The Company did not generate revenue during fiscal year ended January 31, 2026, but subsequently began limited onboarding of initial paying customers in early-stage commercialization. The Company completed significant debt restructuring through non-cash settlements, issuing 22.8 million shares of restricted common stock to extinguish outstanding liabilities.
Forward Guidance
Forward-looking statements include: ability to continue as a going concern; ability to obtain additional financing or raise capital; ability to satisfy existing liabilities and obligations; ability to execute business strategy and commercialization efforts; anticipated future operating results, revenues, margins, and profitability; development and commercialization of software platforms; future market acceptance of products and services. The Company notes that "These activities remain early-stage and may not result in material revenue unless and until the Company is able to expand customer adoption, complete additional onboarding, and obtain sufficient working capital to support commercialization."
Key Risk Factors
The Company faces significant risks including: going concern uncertainties with no material revenue and limited financial resources; dependence on a single executive officer (Michael Rountree) creating key person risk; material weaknesses in internal control over financial reporting; federal illegality of cannabis despite state-level legalization, exposing the Company to potential enforcement actions by federal authorities; regulatory uncertainty regarding HERBO Pay's compliance with money transmitter licensing, Bank Secrecy Act, and financial services regulations; substantial competition from well-capitalized competitors like QuickBooks and Xero; and potential limitations on net operating loss carryforwards under Section 382 due to ownership changes.